Male LUTS, OAB, Sex: natural history. JR Sathiya

Size: px
Start display at page:

Download "Male LUTS, OAB, Sex: natural history. JR Sathiya"

Transcription

1 Male LUTS, OAB, Sex: natural history JR Sathiya

2 Definitions Newer concepts of LUTs Natural history of BPH Prevalence of LUTs

3 Definition BPH- represents a histologic diagnosis that refers to the proliferation of smooth muscle and epithelial cells within the prostatic transition zone. BPE- is defined as prostatic enlargement due to histologic benign prostatic hyperplasia. The term prostatic enlargement should be used in the absence of prostatic histology BOO- is the generic term for obstruction during voiding and is characterized by increased detrusor pressure and reduced urine flow rate.

4 ICS(2002) Definition of LUTS Subjective indicator of a disease or change in condition as perceived by patient, caregiver/partner and may lead him/her to seek help from health care professionals Storage symptoms include increased micturition frequency, nocturia, urinary urgency, and urinary incontinence Voiding symptoms include slow or weak stream, hesitancy, and terminal dribble Postmicturition symptoms include the sensation of incomplete emptying and postmicturition dribble

5 ICS Definition of OAB Urinary urgency, usually accompanied by frequency and nocturia, with or without urgency urinary incontinence, in the absence of urinary tract infection or other obvious pathology.

6 Newer Concepts of LUTs Previously BPH used interchangeably with LUTs. Bladder and prostate as a single functional unit. LUTs- multifactorial LUTs association with chronic disease, metabolic syndrome, sexual dysfunction

7 Figure Diagram showing the relationship between histologic hyperplasia of the prostate (BPH), lower urinary tract symptoms (LUTS), benign prostate enlargement (BPE), and bladder outlet obstruction (BOO). The size of the circles does not represent actual proportions but rather illustrates the partial overlap between the different disease definitions. (From Roehrborn CG. Pathology of benign prostatic hyperplasia. Int J Impot Res 2008;20[Suppl. 3]:S11 8.) Claus G. Roehrborn- Prostatic Hyperplasia: Etiology, Pathophysiology, Epidemiology, and Natural History; Campbell-Walsh Urology 10th Edition

8

9 LUTS Storage Voiding Post- Micturition Urgency Frequency Urge Incontinence Nocturia Slow or Intermittent Stream Straining Hesitation Feeling of Incomplete Emptying Post- Micturition Dribble DO BOO Detrusor Underactivity BOO Detrusor Underactivity (Male/Female) OAB (Male) (Female) BPH Undefined (Male) (Female) BOO Undefined Drug Discovery Today: Therapeutic Strategies Figure 1. Lower urinary tract symptoms (LUTS) by type, key symptoms, underlying pathophysiology and relation to disease entity.

10 Risk factors of BPH/LUTs

11 Natural History of BPH

12 Natural history The natural history of a disease process refers to the prognosis of the disease over time. In other words, the measurement of changes in parameters of interest and the incidence rates of significant outcomes constitute what is commonly referred to as the natural history of a disease.

13 How to elucidate natural history of LUTS? Longitudinal studies of untreated cohorts of men diagnosed with LUTS and clinical BPH by any definition (watchful waiting cohorts). Studies of the behavior of men diagnosed with LUTS and BPH and enrolled in controlled studies of LUTS and BPH (control groups) and receiving: no treatment (compared with active intervention) placebo treatment (compared with medical treatment)eg PLESS, MTOPS sham treatment (compared with device or surgical treatment) Longitudinal studies of unselected (i.e., undiagnosed) men living in the community who are less likely to progress and request or require therapy (longitudinal population-based studies)-olmstead County

14 Problems with untreated cohorts and controlled groups Ethical issues with regards to following up symptomatic men Contact with healthcare personnel establishes bias Requirement of treatment during follow-up causes dropout from study Inclusion/Exclusion criteria renders the study population unnatural

15 Longitudinal population based studies Difficult to conduct Expensive Some bias remains when tests are conducted to understand the disease progression (i.e. flow rate, IPSS, prostate volume, etc) Probably the best in understanding natural history of any disease

16

17 Vol February 1996 Prrnfed 111 U.S.A. NATURAL HISTORY OF PROSTATISM: LONGITUDINAL CHANGES IN VOIDING SYMPTOMS IN COMMUNITY DWELLING MEN STEVEN J. JACOBSEN," CYNTHIA J. GIRMAN, HARRY A. GUESS, THOMAS RHODES, JOSEPH E. OESTERLING AND MICHAEL M. LIEBER From th~a Departments of Health Sciences Research (Section of Clinical Epidemiology) and Urology, Mavo Clinic and Mayo Foundatcon, Rorhester, Minnesota, Merck Research Laboratories, Blue Bell, Pennsylvania, and Michigan Prostate Institute and University of Michigan, Ann Arbor, Michigan Olmsted County Study /95/ $03.00/0 THE JOURNAL OF UROLOGY Copyright by AME~lclw UROLOCICAL ASSOCIATION, INC. VOI. 153, , May 1995 Printed in U.S.A. NATURAL HISTORY OF PROSTATISM: RELATIONSHIP AMONG SYMPTOMS, PROSTATE VOLUME AND PEAK URINARY FLOW RATE CYNTHIA J. GIRMAN, STEVEN J. JACOBSEN, HARRY A. GUESS, JOSEPH E. OESTERLING, CHRISTOPHER G. CHUTE, LAUREL A. PANSER AND MICHAEL M. LIEBER From the Department of Epidemiology, Merck Research Laboratories, West Point, Pennsylvania, Section of Clinical Epidemiology, Health Sciences Research and Department of Urology, Mayo Clinic, Rochester, Minnesota, Departments of Epidemiology and Biostatistics, University of North Carolina, Chapel Hill, North Carolina, and Section of Urology, University of Michigan and The Michigan Prostate Institute, Ann Arbor, Michigan

18 Olmsted County Study The Olmsted County Study was initiated in 1990 and followed for 12 years a randomly selected cohort of 2115 men aged years. It provides the largest body of evidence that BPH is an age-related and progressive disease.

19 Round 1 Round 2 Round replacements 103 replacements 19 dead 33 dead I 95 FIG. 1. Design of Olmsted County Study of Urinary Symptoms and Health Status Among Men. FIG. 2. Movement of baseline cohort across categories of lower urinary tract symptom severity. Round 2o-mild in round 1. Round Ph-moderate to severe in round 1. Round 3c and e-mild in round 2. Round 3d and f-moderate to severe in round 2. Median interval was 18 months between rounds 1 and 2, and 42 months between rounds 1 and 3.

20 Olmsted County Trial At inclusion, 26% of men aged years had moderate to severe LUTS, and this increased to 46% in men aged years The median peak flow rate decreased from 21.2 ml/s to 14.2 ml/s in men in the respective age groups.

21 Olmsted County Study At the follow-up, the severity of LUTS increased and the peak flow rate decreased, with time and age TABLE 1 Changes in IPSS, peak flow rate, prostate size and cumulative incidence of serious outcomes in the Olmsted County study Variable Age, years Overall Number of patients IPSS [5] Baseline, mean Mean (SD) change/year 0.18 (1.22) 0.05 (1.06) 0.18 (1.19) 0.44 (1.35) 0.14 (1.43) Peak flow rate [4] n assessments Baseline, median Median change/year, % Prostate volume [6] Median growth per year, % Cumulative incidence of AUR events over 4 years, n (%) [7] 57 (2.7) 10 (1.2) 9 (1.5) 16 (3.7) 22 (8.7) Cumulative incidence of surgical procedures over 6 years [8], n (%) TURP 45 (2.1) 1 (0.1) 5 (0.9) 21 (4.8) 18 (7.1) MIST 19 (0.9) 0 6 (1.0) 7 (1.6) 6 (2.4) Total 64 (3.0) 1 (0.1) 11 (1.9) 28 (6.5) 24 (9.5) MIST, minimally invasive surgical therapies.

22 Olmsted County Study There was a mean increase in the AUASI/IPSS of 0.18 points per year, ranging from 0.05 in men in their forties to 0.44 in men in their sixties. The annual increase in AUASI/IPSS was low (0.14) in men aged years, but there was no obvious reason for this. The study also showed a decrease in median peak flow rate of 2.1% per year that was also age-related, with men aged 70 years showing a more rapid decline (6.2% per year) than men in their fifties (1.1% per year).

23 FIGURE 2. Mean urinary flow rates measured in 2,113 men from Olmsted County, Minnesota, reveal a decrease in rates with increasing age. Adapted with permission from Girman et al. J Urol 150: ,

24 Olmsted County Study The cumulative incidence of AUR was 2.7% over 4 years, ranging from 1% in men in their fifties to 9% in men aged 70 years. Overall, 3% of men had TURP or a minimally invasive surgical procedure during a 6-year followup, and this was again strongly age-related (from 0.1% in men aged years to 9.5% in men aged years)

25 ) e l c "1 -r-- J-r A 0 - s Time from baseline questionnaire (yr) Plot of cumulative incidence of acute retention by years of followup since com letion of baseline questionnaire. Different lines represent decades orage. Solid line re resents ages 40 to 49, small dashed line ages 50 to 59, medium dasled line ages 60 to 69 and large dashed line ages 70 to 79 years.

26 Olmsted County Study Prostate growth also increased with time by a median of 1.9% per year. Age had little influence on prostate growth but men with large prostates at baseline had higher median growth rates (2.2% per year for prostates of >30 ml vs 1.7% per year for prostates of 30 ml). Serious outcomes, such as AUR and the need for BPH-related surgery, appeared to be low in this community-based population.

27 NATURAL HISTORY OF PROSTATISM -- ms % L y s n r r f m u d ~ ysn rllh = 20 P c w Am (a) 96 with peak flow rate 4 10 mlh (b) % with prostate volune > 50 ml -hatched bars represent subjects with mild or no symptoms. Single hatched bars reflect those with mod

28 Prevalence of Male LUTS and OAB

29 european urology 50 (2006) available at journal homepage: Incontinence EPIC Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study Debra E. Irwin a, *, Ian Milsom b, Steinar Hunskaar c, Kate Reilly d, Zoe Kopp d, Sender Herschorn e, Karin Coyne f, Con Kelleher g, Christian Hampel h, Walter Artibani i, Paul Abrams j Study available at journal homepage: EUROPEAN UROLOGY 56 (2009) Platinum Priority Voiding Dysfunction Editorial by Christopher R. Chapple on pp of this issue Prevalence, Severity, and Symptom Bother of Lower Urinary Tract Symptoms among Men in the EPIC Study: Impact of Overactive Bladder Debra E. Irwin a, *, Ian Milsom b, Zoe Kopp c, Paul Abrams d, Walter Artibani e, Sender Herschorn f

30 EPIC Study The EPIC study was a population-based, crosssectional telephone survey of adults aged >18 yr in five countries All respondents were asked about demographics, the presence of UTI, the presence of individual LUTS using current ICS definitions, and IPSS. IPSS scores were used to assess LUTS severity: 0, none; 1 7, mild; 8 19, moderate; 20 35, severe.

31 EPIC Study The presence of OAB symptoms was determined by a response of yes to either of the following questions: Do you experience a sudden compelling desire to urinate which is difficult to put off?; and Do you leak urine with a sudden compelling desire to urinate? Respondents who reported UTI were excluded from this cohort

32 EPIC Study-Results in the General Population Among men in the general population sample (n = 7210), 62.5% reported experiencing one or more LUTS; 37.7% (ie, 60% of all men reporting any LUTS) reported experiencing only one LUTS subtype, whereas 24.8% (ie, 40% of all men reporting any LUTS) reported experiencing one or more LUTS subtype. The most commonly reported clusters of LUTS subtypes were storage plus voiding LUTS 10.8% of men had urgency (hallmark symptom of OAB)

33 LUTS

34 all men with OAB symptoms (n = 502) reported urgency; 29.3% reported only storage symptoms. Men with OAB symptoms reported a greater prevalence of multiple LUTS subtypes than men in the general population ( p < 0.05). All three LUTS subtypes were reported by 37.3% of men with OAB symptoms, 21.3% reported voiding plus storage symptoms, and 12.2% reported postmicturition plus storage symptoms OAB

35 The most common storage symptom was nocturia among men in the general population (48.6%;), which increased with age (p < 0.05)

36 Nocturia was the second most common storage symptom among men with OAB symptoms (75.3%) after urgency (100%) The prevalence of storage LUTS increased with age ( p < 0.05)

37 Terminal dribble (general population, 14.2%; OAB cases, 36.9%) and the sensation of incomplete emptying (general population, 13.5%; OAB cases, 36.9%)were the most frequently reported voiding and postmicturition symptoms

38 Among men with OAB symptoms, prevalence of voiding and postmicturition LUTS were variable with increasing age

39 Fig. 3 Distribution (%) of number of lower urinary tract symptoms (LUTS) by age group among (a) men in the general population (n = 7210) and (b) men in the overactive bladder (OAB) population (n = 502). The number of individual LUTS reported by each respondent increased with age ( p < 0.05), particularly among men with OAB symptoms The overall prevalence of any LUTS increased with age in the general population, from 51.3% for men <40 yr to 80.7% for men >60 yr ( p < 0.05).

40 Symptom severity & bother More than 6% of men in the general population reported moderate (5.4%) or severe (0.7%) LUTS, as scored by the IPSS. By contrast, almost 30% of men with OAB symptoms reported moderate (25.5%) or severe (4.4%) LUTS. For both populations, the proportional increase in men reporting any LUTS (mild, moderate, or severe) with age was significant (p<0.05). Overall, mean IPSS was nearly three times higher among men with OAB symptoms versus the general population sample

41 Sex

42 Boston Area Community Health (BACH) survey population-based random sample survey on prevalence of LUTS and association with risk factors Association with chronic diseases eg DM, hypertension, heart disease,depression Association with metabolic syndrome Association with erectile dysfunction

43 Relationship Between Lower Urinary Tract Symptoms and Erectile Dysfunction: Results From the Boston Area Community Health Survey Sara T. Brookes,* Carol L. Link, Jenny L. Donovan and John B. McKinlay From the Department of Social Medicine, University of Bristol, Bristol, United Kingdom and New England Research Institutes (CLL, JBM), Watertown, Massachusetts d severity by age and AUA-SI score. Moderate and severe LUTS were combined due to relatively smal

44 European Urology European Urology 44 (2003) Lower UrinaryTract Symptoms and Male Sexual Dysfunction: The Multinational Survey of the Aging Male (MSAM-7) Raymond Rosen a,*, Jens Altwein b, Peter Boyle c, Roger S. Kirby d, B. Lukacs e, Eric Meuleman f, Michael P. O Leary g, Paolo Puppo h, Chris Robertson c, Francois Giuliano i Sexual activity was reported by 83% of the sample, with 71% reporting at least one episode of sexual activity during the previous 4 weeks. Sexual disorders and their bothersomeness were strongly related to both age and severity of LUTS

45 Base: Total sample LUTS Severity Age Cohort Mild Moderate Servere Mild Moderate Servere Mild Moderate Servere years years years Fig. 1. Average number of sexual activities, including intercourse, per month. (a) In% LUTS Severity Age Cohort Mild Base: Total sample Moderate Severe Mild Net reduction of stiffness No, I cannot get an erection Moderate Severe Mild Moderate Severe years years years

Prevalence, Severity, and Symptom Bother of Lower Urinary Tract Symptoms among Men in the EPIC Study: Impact of Overactive Bladder

Prevalence, Severity, and Symptom Bother of Lower Urinary Tract Symptoms among Men in the EPIC Study: Impact of Overactive Bladder EUROPEAN UROLOGY 56 (2009) 14 20 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Voiding Dysfunction Editorial by Christopher R. Chapple on pp. 21 23 of this

More information

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center Diagnostic approach to LUTS in men Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center Classification of LUTS Storage symptoms Voiding symptoms Post micturition

More information

VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS

VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS VOIDING DYSFUNCTION IN ELDERLY MALE CURRENT STATUS DR. FRANCIS LEE Voiding dysfunction Storage Emptying Common voiding dysfunction in elderly male Emptying BPH Storage Incontinence Overactive bladder Post-prostatectomy

More information

NOTE: This policy is not effective until April 1, Transurethral Water Vapor Thermal Therapy of the Prostate

NOTE: This policy is not effective until April 1, Transurethral Water Vapor Thermal Therapy of the Prostate NOTE: This policy is not effective until April 1, 2019. Medical Policy Manual Surgery, Policy No. 210 Transurethral Water Vapor Thermal Therapy of the Prostate Next Review: December 2019 Last Review: December

More information

Benign Prostatic Hyperplasia (BPH):

Benign Prostatic Hyperplasia (BPH): Benign Prostatic Hyperplasia (BPH): Evidence Based Guidelines for Primary Care Providers Jeanne Martin, DNP, ANP-BC Objectives 1. Understand the pathophysiology and prevalence of BPH 2. Select the appropriate

More information

NIH Public Access Author Manuscript J Urol. Author manuscript; available in PMC 2010 May 4.

NIH Public Access Author Manuscript J Urol. Author manuscript; available in PMC 2010 May 4. NIH Public Access Author Manuscript Published in final edited form as: J Urol. 2009 December ; 182(6): 2819 2824. doi:10.1016/j.juro.2009.08.086. Intravesical Prostatic Protrusion in Men in Olmsted County,

More information

Key words: Lower Urinary Tract Symptoms (LUTS), Prostatic Hyperplasia, Alpha-1 Adrenoceptor Antagonists, Tamsulosin, Terazosin.

Key words: Lower Urinary Tract Symptoms (LUTS), Prostatic Hyperplasia, Alpha-1 Adrenoceptor Antagonists, Tamsulosin, Terazosin. The Professional Medical Journal DOI: 10.17957/TPMJ/17.4102 ORIGINAL PROF-4102 PROSTATIC HYPERPLASIA; COMPARISON BETWEEN TAMSULOSIN AND TERAZOSIN FOR EFFICACY IN MEDICAL MANAGEMENT OF LOWER URINARY TRACT

More information

50% of men. 90% of men PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS. Want more information? What are the symptoms?

50% of men. 90% of men PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS. Want more information? What are the symptoms? PATIENT FACTSHEET: BPH CONDITION AND TREATMENTS What is Benign Prostatic Hyperplasia (enlarged prostate)? Benign prostatic hyperplasia (BPH) is a noncancerous enlargement of the prostate, the gland that

More information

Alpha antagonists from initial concept to routine clinical practice

Alpha antagonists from initial concept to routine clinical practice european urology 50 (2006) 635 642 available at www.sciencedirect.com journal homepage: www.europeanurology.com Editorial 50th Anniversary Alpha antagonists from initial concept to routine clinical practice

More information

The Enlarged Prostate Symptoms, Diagnosis and Treatment

The Enlarged Prostate Symptoms, Diagnosis and Treatment The Enlarged Prostate Symptoms, Diagnosis and Treatment MAC00031-01 Rev G Financial support for this seminar has been provided by NeoTract, Inc., the manufacturer of the UroLift System. 1 Today s Agenda

More information

The Hallmarks of BPH Progression and Risk Factors

The Hallmarks of BPH Progression and Risk Factors European Urology Supplements European Urology Supplements 2 (23) 2 7 The Hallmarks of BPH Progression and Risk Factors M. Emberton * Institute of Urology and Nephrology, University College London, 48 Riding

More information

BPH: a present and future perspective on health impact

BPH: a present and future perspective on health impact BPH: a present and future perspective on health impact Burden of disease in men with moderate LUTS Dalibor Pacík This presentation is financially supported by GlaxoSmithKline. CZ/DUTT/0019/12 Men with

More information

The patient, your co-pilot in assessing LUTS

The patient, your co-pilot in assessing LUTS The patient, your co-pilot in assessing LUTS Frank Van der Aa Leuven, Belgium This symposium is supported by Astellas Pharma Europe Ltd., including speaker honoraria and production of materials the slides

More information

BJUI. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction

BJUI. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction 21 THE AUTHORS; 21 Lower Urinary Tract WORLDWIDE PREVALENCE OF LUTS IRWIN ET AL. BJUI Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder

More information

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH INTRODUCTION (1) Part of male sexual reproductive organ Size

More information

EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT

EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT Basrah Journal Of Surgery EVALUATION OF THE EFFICACY OF TADALAFIL IN IMPROVING LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT MB, ChB, FIBMS, Assistant Professor

More information

Therapeutic Strategies for Managing BPH Progression

Therapeutic Strategies for Managing BPH Progression european urology supplements 5 (2006) 997 1003 available at www.sciencedirect.com journal homepage: www.europeanurology.com Therapeutic Strategies for Managing BPH Progression John M. Fitzpatrick a, *,

More information

Management of LUTS. Simon Woodhams February 2012

Management of LUTS. Simon Woodhams February 2012 Management of LUTS Simon Woodhams February 2012 The management of lower urinary tract symptoms (LUTS) in men Implementing NICE guidance May 2010 NICE clinical guideline 97 Background Lower urinary tract

More information

Benign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary

Benign Prostatic Hyperplasia. Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary Benign Prostatic Hyperplasia Jay Lee, MD, FRCSC Clinical Associate Professor University of Calgary Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied,

More information

A SURVEY ON LOWER URINARY TRACT SYMPTOMS (LUTS) AMONG PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH) IN HOSPITAL UNIVERSITI SAINS MALAYSIA (HUSM)

A SURVEY ON LOWER URINARY TRACT SYMPTOMS (LUTS) AMONG PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH) IN HOSPITAL UNIVERSITI SAINS MALAYSIA (HUSM) Malaysian Journal of Medical Sciences, Vol. 14, No. 2, July 2007 (67-71) SHORT COMMUNICATION A SURVEY ON LOWER URINARY TRACT SYMPTOMS (LUTS) AMONG PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH) IN HOSPITAL

More information

Chapter 4: Research and Future Directions

Chapter 4: Research and Future Directions Chapter 4: Research and Future Directions Introduction Many of the future research needs listed in the 1994 Agency for Health Care Policy and Research (AHCPR) clinical practice guideline Benign Prostatic

More information

Association of BPH with OAB: The Plumbing or the Pump?

Association of BPH with OAB: The Plumbing or the Pump? Association of BPH with OAB: The Plumbing or the Pump? Ryan P. Terlecki, MD FACS Associate Professor of Urology Director, Men s Health Clinic Director, GURS Fellowship in Reconstructive Urology, Prosthetic

More information

Shrestha A, Chalise PR, Sharma UK, Gyawali PR, Shrestha GK, Joshi BR. Department of Surgery, TU Teaching Hospital, Maharajgunj, Kathmandu, Nepal

Shrestha A, Chalise PR, Sharma UK, Gyawali PR, Shrestha GK, Joshi BR. Department of Surgery, TU Teaching Hospital, Maharajgunj, Kathmandu, Nepal Original Article Intravesical Prostatic Protrusion is better than Prostate Volume in Predicting Symptom Severity in Benign Prostatic Hyperplasia: A Prospective Clinical Study Shrestha A, Chalise PR, Sharma

More information

Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile Function

Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile Function www.kjurology.org DOI:10.4111/kju.2011.52.1.49 Sexual Dysfunction Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile

More information

Original Article - Sexual Dysfunction

Original Article - Sexual Dysfunction www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.9.608 Original Article - Sexual Dysfunction http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.9.608&domain=pdf&date_stamp=2014-09-16

More information

Evaluation of Sexual Dysfunction in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Patients

Evaluation of Sexual Dysfunction in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Patients Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2018/10 Evaluation of Sexual Dysfunction in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Patients N. Narayanamoorthy,

More information

ISSN: (Print) (Online) Journal homepage:

ISSN: (Print) (Online) Journal homepage: Archives of Andrology Journal of Reproductive Systems ISSN: 0148-5016 (Print) (Online) Journal homepage: http://www.tandfonline.com/loi/iaan19 CHANGE IN INTERNATIONAL PROSTATE SYMPTOM SCORE AFTER TRANSURETHRAL

More information

The Evolution of Combination Therapy. US men eligible for BPH treatment * with projected population changes

The Evolution of Combination Therapy. US men eligible for BPH treatment * with projected population changes The Management of BPH & The Impact of Combination Therapy Results Combination of Avodart and Tamsulosin (CombAT) Medical Therapy of Prostate Symptoms (MTOPS) Dr. Jack Barkin, md, fics, facs, dabu, Mcert

More information

RELATIONSHIPS BETWEEN AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX, PROSTATE VOLUME, PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

RELATIONSHIPS BETWEEN AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX, PROSTATE VOLUME, PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA American Urological Association symptom index for BPH RELATIONSHIPS BETWEEN AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX, PROSTATE VOLUME, AND DISEASE-SPECIFIC QUALITY OF LIFE QUESTION IN PATIENTS WITH

More information

Prostate Gland Volume and Its Relationship to Complications of Benign Prostatic Enlargement

Prostate Gland Volume and Its Relationship to Complications of Benign Prostatic Enlargement IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 14, Issue 6 Ver. II (Jun. 2015), PP 33-37 www.iosrjournals.org Prostate Gland Volume and Its Relationship

More information

Evaluation of Recent Trends in Treatment Patterns Among Men With Benign Prostatic Hyperplasia

Evaluation of Recent Trends in Treatment Patterns Among Men With Benign Prostatic Hyperplasia 469245JMHXXX10.1177/1557988312469245A merican Journal of Men s HealthKruep et al. Article Evaluation of Recent Trends in Treatment Patterns Among Men With Benign Prostatic Hyperplasia American Journal

More information

Lower Urinary Tract Symptoms BPH vs OAB FLOW vs VOLUME. Matt T. Rosenberg, MD Family Practice Mid Michigan Health Centers Jackson, Michigan

Lower Urinary Tract Symptoms BPH vs OAB FLOW vs VOLUME. Matt T. Rosenberg, MD Family Practice Mid Michigan Health Centers Jackson, Michigan Lower Urinary Tract Symptoms BPH vs OAB FLOW vs VOLUME Matt T. Rosenberg, MD Family Practice Mid Michigan Health Centers Jackson, Michigan 1 Definition of OAB Syndrome or symptom complex defined as urgency,

More information

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP

Increasing Awareness, Diagnosis, and Treatment of BPH, LUTS, and EP Introduction to Enlarged Prostate E. David Crawford, MD Professor of Surgery (Urology) and Radiation Oncology Head, Urologic Oncology E. David Crawford Endowed Chair in Urologic Oncology University of

More information

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms Storage Symptoms Frequency, urgency, incontinence, Nocturia Voiding Symptoms Hesitancy, poor flow, intermittency,

More information

PROSPERO International prospective register of systematic reviews

PROSPERO International prospective register of systematic reviews PROSPERO International prospective register of systematic reviews Systematic review of the diagnostic performance of non-invasive tests in diagnosing bladder outlet obstruction or detrusor underactivity

More information

Guideline for the primary care management of male lower urinary tract symptoms

Guideline for the primary care management of male lower urinary tract symptoms review Article GUIDELINES FOR LUTS M.J. SPEAKMAN et al. As my Comment in the first section of the journal suggested, the MTOPS results have offered the possibility to general practitioners of reducing

More information

Employers in the United States have become more cognizant

Employers in the United States have become more cognizant n report n Impact of Overactive Bladder on Work Productivity in the United States: Results From EpiLUTS Chris C. Sexton, PhD; Karin S. Coyne, PhD, MPH; Vasudha Vats, MPH; Zoe S. Kopp, PhD, MPH; Debra E.

More information

EUROPEAN UROLOGY 63 (2013)

EUROPEAN UROLOGY 63 (2013) EUROPEAN UROLOGY 63 (2013) 158 165 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Voiding Dysfunction Editorial by Christian Gratzke and Karl-Erik Andersson

More information

Diagnosis and Mangement of Nocturia in Adults

Diagnosis and Mangement of Nocturia in Adults Diagnosis and Mangement of Nocturia in Adults Christopher Chapple Professor of Urology Sheffield Teaching Hospitals University of Sheffield Sheffield Hallam University UK 23 rd October 2015 Terminology

More information

All about the Prostate

All about the Prostate MEN S HEALTH Dr Nick Pendleton January 16 th 2018 All about the Prostate 1 What does it do? Functions of the Prostate 1. Secretes Prostatic Fluid slightly alkaline fluid, 30% of volume of seminal fluid,

More information

Voiding Dysfunction Block lecture, 5 th year student. Choosak Pripatnanont, Department of Surgery, PSU.

Voiding Dysfunction Block lecture, 5 th year student. Choosak Pripatnanont, Department of Surgery, PSU. Voiding Dysfunction 2009 Block lecture, 5 th year student. Choosak Pripatnanont, Department of Surgery, PSU. Objectives Understand and explain physiologic function and dysfunction of lower urinary tract.

More information

Can men with prostates sized 80 ml or larger be managed conservatively?

Can men with prostates sized 80 ml or larger be managed conservatively? Original Article - Lower Urinary Tract Dysfunction Investig Clin Urol 2017;58:359-364. pissn 2466-0493 eissn 2466-054X Can men with prostates sized 80 ml or larger be managed conservatively? Alvin Lee,

More information

Benign Prostatic Hyperplasia: Update on Innovative Current Treatments

Benign Prostatic Hyperplasia: Update on Innovative Current Treatments Benign Prostatic Hyperplasia: Update on Innovative Current Treatments Michael Ferrandino, MD As.soc Professor Director of Minimally Invasive Urologic Surgery Division of Urologic Surgery Duke University

More information

Department of Urology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX

Department of Urology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX NEW PERSPECTIVES ON BPH 5- -Reductase Inhibitors Prevent the Progression of Benign Prostatic Hyperplasia Claus G. Roehrborn, MD Department of Urology, The University of Texas Southwestern Medical Center

More information

Impact of smoking on Lower Urinary Tract Symptoms (LUTS) - Single tertiary centre experience

Impact of smoking on Lower Urinary Tract Symptoms (LUTS) - Single tertiary centre experience International Journal of Scientific and Research Publications, Volume 6, Issue 5, May 2016 119 Impact of smoking on Lower Urinary Tract Symptoms (LUTS) - Single tertiary centre experience AUB Pethiyagoda

More information

Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital

Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital 01/02/2018 Lower Urinary Tract Symptoms LUTS - one of

More information

Patient Information. Lower Urinary Tract Symptoms (LUTS) and Diagnosis of BPE

Patient Information. Lower Urinary Tract Symptoms (LUTS) and Diagnosis of BPE Patient Information English 32 Lower Urinary Tract Symptoms (LUTS) and Diagnosis of BPE Symptoms The underlined terms are listed in the glossary. Benign prostatic enlargement (BPE) can affect the way you

More information

As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder LUTS 2. Prevalence of BPH LUTS 5

As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder LUTS 2. Prevalence of BPH LUTS 5 BPH / LUTS Dr Jonny Coxon MA MD MRCS MRCGP DRCOG Beaconsfield Medical Practice, Brighton As man draws near the common goal Can anything be sadder Than he who, master of his soul Is servant to his bladder

More information

INJINTERNATIONAL. Sociodemographic Factors Related to Lower Urinary Tract Symptoms in Men: A Korean Community Health Survey.

INJINTERNATIONAL. Sociodemographic Factors Related to Lower Urinary Tract Symptoms in Men: A Korean Community Health Survey. Official Journal of Korean Continence Society / Korean Society of Urological Research / The Korean Children s Continence and Enuresis Society / The Korean Association of Urogenital Tract Infection and

More information

Male LUT/BPH. Current Issues and Unmet Needs

Male LUT/BPH. Current Issues and Unmet Needs Male LUT/BPH Current Issues and Unmet Needs What do we know, what don t we know? What do we need to know? Kevin T. McVary, MD-FACS Professor and Chair of Urology Southern Illinois University School of

More information

During the past decade, numerous

During the past decade, numerous Benign prostatic hyperplasia (BPH) is one of the most common diseases of aging men. It is estimated that by age 60 years, greater than 50% of men will have histologically documented evidence of the disease.

More information

OVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1

OVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1 PATIENT INFORMATION BPH affects more than 500 million men worldwide, with many men suffering from symptoms of enlarged prostate. 1 You no longer have to be one of them! OVER 70% OF MEN IN THEIR 60s HAVE

More information

The impact of overactive bladder on quality of life in south of China

The impact of overactive bladder on quality of life in south of China The impact of overactive bladder on quality of life in south of China Dong Chen, Yining Li * Department of Urology, Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, China. * Corresponding

More information

LUTS A plea for a holistic approach. HUBERT GALLAGHER, MCh; FRCSI, FRCSI(Urol) Head of Urology Beacon Hospital

LUTS A plea for a holistic approach. HUBERT GALLAGHER, MCh; FRCSI, FRCSI(Urol) Head of Urology Beacon Hospital LUTS A plea for a holistic approach. HUBERT GALLAGHER, MCh; FRCSI, FRCSI(Urol) Head of Urology Beacon Hospital LUTS- Classification Men LUTS can be divided into: Storage Voiding Frequency Nocturia Urgency

More information

Lower UrinaryTract Symptoms (LUTS) and Sexual Function in Both Sexes

Lower UrinaryTract Symptoms (LUTS) and Sexual Function in Both Sexes European Urology European Urology 46 (2004) 229 234 Lower UrinaryTract Symptoms (LUTS) and Sexual Function in Both Sexes Bjarne Lühr Hansen * Research Unit of General Practice, University of Southern Denmark,

More information

Effect of Transurethral Resection of the Prostate Based on the Degree of Obstruction Seen in Urodynamic Study

Effect of Transurethral Resection of the Prostate Based on the Degree of Obstruction Seen in Urodynamic Study www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.12.840 Voiding Dysfunction/Female Urology Effect of Transurethral Resection of the Prostate Based on the Degree of Obstruction Seen in Urodynamic

More information

Cialis. Cialis (tadalafil) Description

Cialis. Cialis (tadalafil) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.06.02 Subject: Cialis Page: 1 of 5 Last Review Date: September 18, 2015 Cialis Description Cialis (tadalafil)

More information

REPORTS. Clinical and Economic Outcomes in Patients Treated for Enlarged Prostate

REPORTS. Clinical and Economic Outcomes in Patients Treated for Enlarged Prostate Clinical and Economic Outcomes in Patients Treated for Enlarged Prostate Michael James Naslund, MD, MBA; Muta M. Issa, MD, MBA; Amy L. Grogg, PharmD; Michael T. Eaddy, PharmD, PhD; and Libby Black, PharmD

More information

INJINTERNATIONAL. Original Article INTRODUCTION

INJINTERNATIONAL. Original Article INTRODUCTION Official Journal of Korean Continence Society / Korean Society of Urological Research / The Korean Children s Continence and Enuresis Society / The Korean Association of Urogenital Tract Infection and

More information

ORIGINAL ARTICLE. Key words benign prostatic hyperplasia, bother, lower urinary tract symptoms, quality of life, tamsulosin

ORIGINAL ARTICLE. Key words benign prostatic hyperplasia, bother, lower urinary tract symptoms, quality of life, tamsulosin LUTS (2012) 4, 45 50 ORIGINAL ARTICLE Correlations among Lower Urinary Tract Symptoms, Bother, and Quality of Life in Patients with Benign Prostatic Hyperplasia and Associated Fluctuations with Tamsulosin

More information

BPH / LUTS. Prevalence. Prevalence of BPH. It is abnormal NOT to have benign growth of the prostate with increasing age. Prevalence.

BPH / LUTS. Prevalence. Prevalence of BPH. It is abnormal NOT to have benign growth of the prostate with increasing age. Prevalence. BPH / LUTS Dr Jonny Coxon MA MD MRCS MRCGP DRCOG FECSM Beaconsfield Medical Practice, Brighton & Brighton & Sussex Universities NHS Trust As man draws near the common goal Can anything be sadder Than he

More information

A Comparison of the Frequencies of Medical Therapies for Overactive Bladder in Men and Women: Analysis of More Than 7.2 Million Aging Patients

A Comparison of the Frequencies of Medical Therapies for Overactive Bladder in Men and Women: Analysis of More Than 7.2 Million Aging Patients EUROPEAN UROLOGY 57 (2010) 586 591 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Voiding Dysfunction Editorial by Roger Dmochowski on pp. 592 593 of this

More information

Office based non-oncology urology trials Richard W. Casey, MD, 1 Jack Barkin, MD 2

Office based non-oncology urology trials Richard W. Casey, MD, 1 Jack Barkin, MD 2 Office based non-oncology urology trials Richard W. Casey, MD, 1 Jack Barkin, MD 2 1 The Male Health Centre, Oakville, Ontario, Canada 2 Humber River Regional Hospital, University of Toronto, Toronto,

More information

Questioning questions about symptoms of benign prostatic hyperplasia

Questioning questions about symptoms of benign prostatic hyperplasia Family Practice Vol. 18, No. 3 Oxford University Press 2001 Printed in Great Britain Questioning questions about symptoms of benign prostatic hyperplasia Ejda Hassler, Ingvar Krakau, Lars Häggarth, Lars

More information

L ower urinary tract symptoms (LUTS) are a major health problem and are prevalent in men aged.45 years1 3.

L ower urinary tract symptoms (LUTS) are a major health problem and are prevalent in men aged.45 years1 3. OPEN SUBJECT AREAS: UROGENITAL DISEASES DRUG DEVELOPMENT Received 23 October 2013 Accepted 15 January 2014 Published 4 February 2014 Correspondence and requests for materials should be addressed to P.H.

More information

Treating BPH: Comparing Rezum UroLift and HoLEP

Treating BPH: Comparing Rezum UroLift and HoLEP Treating BPH: Comparing Rezum UroLift and HoLEP Scott M. Cheney MD Mayo Clinic Arizona 2018 MFMER slide-1 Welcome to AZ 2018 MFMER slide-2 Outline Background on BPH, Rezum, Urolift, HoLEP AUA Guideline

More information

University of Bristol - Explore Bristol Research

University of Bristol - Explore Bristol Research Uren, A. D., Cotterill, N., Harding, C., Hillary, C., Chapple, C., Klaver, M.,... Abrams, P. (2017). Qualitative Exploration of the Patient Experience of Underactive Bladder. European Urology. DOI: 10.1016/j.eururo.2017.03.045

More information

Mr. GIT KAH ANN. Pakar Klinikal Urologi Hospital Kuala Lumpur.

Mr. GIT KAH ANN. Pakar Klinikal Urologi Hospital Kuala Lumpur. Mr. GIT KAH ANN Pakar Klinikal Urologi Hospital Kuala Lumpur drgitka@yahoo.com 25 Jan 2007 HIGHLIGHTS Introduction ICS Definition Making a Diagnosis Voiding Chart Investigation Urodynamics Ancillary Investigations

More information

김준철 가톨릭대학교의과대학비뇨기과학교실

김준철 가톨릭대학교의과대학비뇨기과학교실 비뇨기계자율신경병증의치료 김준철 가톨릭대학교의과대학비뇨기과학교실 Introduction Urologic complications have increasingly become a concern in those affected by DM Genitourinary problems are included among these complications, related

More information

Prevalence of Lower Urinary Tract Symptoms in Indigenous and Non-indigenous Women in Eastern Taiwan

Prevalence of Lower Urinary Tract Symptoms in Indigenous and Non-indigenous Women in Eastern Taiwan Volume 109 Number 3 March 2010 Hepatitis C virus therapy Psychiatric morbidity in HIV-infected male prisoners Intravascular large B cell lymphoma in Taiwan Chinese incontinentia pigmenti NEMO gene mutations

More information

The Journal of International Medical Research 2012; 40:

The Journal of International Medical Research 2012; 40: The Journal of International Medical Research 2012; 40: 899 908 Comparison of α-blocker Monotherapy and α-blocker Plus 5α-Reductase Inhibitor Combination Therapy Based on Prostate Volume for Treatment

More information

Cialis. Cialis (tadalafil) Description

Cialis. Cialis (tadalafil) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.40.22 Subject: Cialis Page: 1 of 5 Last Review Date: September 15, 2017 Cialis Description Cialis (tadalafil)

More information

Neurogenic bladder. Neurogenic bladder is a type of dysfunction of the bladder due to neurological disorder.

Neurogenic bladder. Neurogenic bladder is a type of dysfunction of the bladder due to neurological disorder. Definition: Neurogenic bladder Neurogenic bladder is a type of dysfunction of the bladder due to neurological disorder. Types: Nervous system diseases: Congenital: like myelodysplasia like meningocele.

More information

The potential for NX-1207 in benign prostatic hyperplasia: an update for clinicians

The potential for NX-1207 in benign prostatic hyperplasia: an update for clinicians Therapeutic Advances in Chronic Disease Review The potential for NX-1207 in benign prostatic hyperplasia: an update for clinicians Neal Shore and Barrett Cowan Ther Adv Chronic Dis (2011) 2(6) 377 383

More information

Combination Drug Therapy for Benign Prostatic Hyperplasia (BPH)

Combination Drug Therapy for Benign Prostatic Hyperplasia (BPH) The Annals of African Surgery www.sskenya.org Combination Drug Therapy for Benign Prostatic Hyperplasia (BPH) Author: Oliech J.S. FRCS, Affiliation: Department of Surgery, University of Nairobi. P.O. Box

More information

Sexual Dysfunction in Aging Men With Lower Urinary Tract Symptoms

Sexual Dysfunction in Aging Men With Lower Urinary Tract Symptoms Sexual Dysfunction and Infertility Sexual Dysfunction in Aging Men With Lower Urinary Tract Symptoms Darab Mehraban, Gholam Hossein Naderi, Seyed Reza Yahyazadeh, Mahdi Amirchaghmaghi Introduction: Our

More information

Benign Prostatic Hyperplasia (BPH) Important Papers / Landmark. Vijayan Manogran

Benign Prostatic Hyperplasia (BPH) Important Papers / Landmark. Vijayan Manogran Benign Prostatic Hyperplasia (BPH) Important Papers / Landmark Studies Vijayan Manogran MTOPS & CombAT PLESS SMART ALTESS ALF-ONE VA PREDICT EPICS Landmark Studies MTOPS Medical Therapy of Prostatic Symptoms

More information

THE ACONTRACTILE BLADDER - FACT OR FICTION?

THE ACONTRACTILE BLADDER - FACT OR FICTION? THE ACONTRACTILE BLADDER - FACT OR FICTION? Jacob Golomb Department of Urology Chaim Sheba Medical Center Tel Hashomer NEUROGENIC UNDERACTIVE DETRUSOR Central (complete/incomplete): Spinal cord injury-

More information

PATIENT INFORMATION 2017 NeoTract, Inc. All rights reserved. Printed in the USA. MAC Rev A

PATIENT INFORMATION 2017 NeoTract, Inc. All rights reserved. Printed in the USA. MAC Rev A PATIENT INFORMATION OVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1 BPH affects more than 500 million men worldwide, with many men suffering from symptoms of enlarged prostate. 1 You no longer have

More information

Ambulatory Try off Catheter (ATOC) Program for the Patient with Acute Retention of Urine Outpatient Service

Ambulatory Try off Catheter (ATOC) Program for the Patient with Acute Retention of Urine Outpatient Service Ambulatory Try off Catheter (ATOC) Program for the Patient with Acute Retention of Urine Outpatient Service Mr. Tang, Chi Chiu Kevin (APN) Urology Center Department of Surgery Kwong Wah Hospital Redevelopment

More information

α-blocker Monotherapy and α-blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years Long-Term Results

α-blocker Monotherapy and α-blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years Long-Term Results www.kjurology.org http://dx.doi.org/10.4111/kju.2012.53.4.248 Voiding Dysfunction α-blocker Monotherapy and α-blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia;

More information

BPH: Social Impact and Patient s Perspective

BPH: Social Impact and Patient s Perspective european urology supplements 5 (2006) 991 996 available at www.sciencedirect.com journal homepage: www.europeanurology.com BPH: Social Impact and Patient s Perspective Mark Emberton a, *, Guiseppe Martorana

More information

PHARMACEUTICALS ISSUE 2.0 APRIL 1996 FINASTERIDE: CLINICAL AND ECONOMIC IMPACTS

PHARMACEUTICALS ISSUE 2.0 APRIL 1996 FINASTERIDE: CLINICAL AND ECONOMIC IMPACTS TECHNOLOGY OVERVIEW: PHARMACEUTICALS ISSUE 2.0 APRIL 1996 FINASTERIDE: CLINICAL AND ECONOMIC IMPACTS prepared by Dr. Nicolaas Otten, Pharm D. Coordinator, Pharmaceutical Assessment, CCOHTA This overview

More information

Original Article. J Fac Med Baghdad 119. Nibbras I. AL-Hamdani* Ali W. Zeki*** Introduction:

Original Article. J Fac Med Baghdad 119. Nibbras I. AL-Hamdani* Ali W. Zeki*** Introduction: Original Article The Efficacy of Solifenacin Added to Α-Adrenergic Antagonists in the Treatment of Lower Urinary Tract Symptoms in Males with Benign Prostate Hyperplasia (The Iraqi Experience) Nibbras

More information

Prostate Disease. Chad Baxter, MD

Prostate Disease. Chad Baxter, MD Prostate Disease Chad Baxter, MD Managing BPH and LUTS Chad Baxter, MD Department of Urology cbaxter@mednet.ucla.edu 33 nd Annual UCLA Intensive Course in Geriatric Medicine & Board Review Prevalence of

More information

DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI DOWNLOAD OR READ : TREATMENT OF BENIGN PROSTATIC HYPERPLASIA PDF EBOOK EPUB MOBI Page 1 Page 2 treatment of benign prostatic hyperplasia treatment of benign prostatic pdf treatment of benign prostatic

More information

LUTS after TURP: How come and how to manage? Matthias Oelke

LUTS after TURP: How come and how to manage? Matthias Oelke LUTS after TURP: How come and how to manage? Matthias Oelke Department of Urology Global Congress on LUTD, Rome, 26 th June 2015 Disclosures Consultant, speaker, trial participant and/or research grants

More information

A unit of International Journal Foundation Page I 96

A unit of International Journal Foundation Page I 96 Occupational distribution of Patients with LUTS Single tertiary center experience. Part -4 (Medical Science) Chapter-III August/Vol.4.0/Issue-II ISSN NO : 2456-1045 ISSN CODE: 2456-1045 (Online) (ICV-MDS

More information

Current drug management of BPH in primary care Claire Taylor MRCS, Charlotte Foley MRCS and Roger Kirby MA, MD, FRCS Urol

Current drug management of BPH in primary care Claire Taylor MRCS, Charlotte Foley MRCS and Roger Kirby MA, MD, FRCS Urol Drug review BPH Current drug management of BPH in primary care Claire Taylor MRCS, Charlotte Foley MRCS and Roger Kirby MA, MD, FRCS Urol Skyline Imaging Ltd The range of drug treatments for BPH, alone

More information

Office Management of Benign Prostatic Enlargement

Office Management of Benign Prostatic Enlargement Focus on CME at McGill University Office Management of Benign Prostatic Enlargement Symptomatic benign prostate enlargement is a common medical problem encountered in our aging society. Watchful waiting,

More information

Convective RF Water Vapor Energy Ablation Effectively Treats LUTS due to BPH, Preserves Erectile and Ejaculatory Function

Convective RF Water Vapor Energy Ablation Effectively Treats LUTS due to BPH, Preserves Erectile and Ejaculatory Function 1 Convective RF Water Vapor Energy Ablation Effectively Treats LUTS due to BPH, Preserves Erectile and Ejaculatory Function Nikhil Gupta, Tobias S. Köhler, Kevin T. McVary SIU School of Medicine Division

More information

PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA

PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA St. Louis Hospital PROSTATIC EMBOLIZATION FOR BENIGN HYPERPLASIA INITIAL CLINICAL RESULTS Faculty of Medical Sciences New University of Lisbon JOÃO PISCO LUÍS CAMPOS PINHEIRO TIAGO BILHIM HUGO RIO TINTO

More information

The prevalence of lower urinary tract symptoms in population aged 40 years or over, in South Korea

The prevalence of lower urinary tract symptoms in population aged 40 years or over, in South Korea Original Article - Lower Urinary Tract Dysfunction pissn 2466-493 eissn 2466-4X The prevalence of lower urinary tract symptoms in population aged 4 years or over, in South Korea Tag Keun Yoo 1, Kyu-Sung

More information

Elements for a Public Summary

Elements for a Public Summary VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Benign prostatic hyperplasia (BPH), also called benign prostatic hypertrophy or benign prostatic obstruction, is a condition in

More information

A prospective study of sexual dysfunction in patients with benign prostatic hyperplasia

A prospective study of sexual dysfunction in patients with benign prostatic hyperplasia International Surgery Journal Leelakrishna P et al. Int Surg J. 218 Mar;5(3):82-89 http://www.ijsurgery.com pissn 2349-335 eissn 2349-292 Original Research Article DOI: http://dx.doi.org/1.1823/2349-292.isj2185

More information

Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014

Overview. Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia. Iain McAuley September 15, 2014 Urology Dine and Learn: Erectile Dysfunction & Benign Prostatic Hyperplasia Iain McAuley September 15, 2014 Overview Review of the most recent guidelines for ED and BPH ED Guidelines CUA 2006 AUA 2011

More information

PRABHAKAR SINGH*, MANOJ INDURKAR, AMITA SINGH, PALLAVI INDURKAR

PRABHAKAR SINGH*, MANOJ INDURKAR, AMITA SINGH, PALLAVI INDURKAR Academic Sciences International Journal of Current Pharmaceutical Research ISSN- 0975-7066 Vol 5, Issue 1, 2013 Research Article COMPARISON OF THE EFFICACY AND SAFETY OF TAMSULOSIN (0.4 V/S (and) FINASTERIDE

More information